Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 2Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 123Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 313Lymphoma 309Lymphoma, Non-Hodgkin 227Lymphoma, Large B-Cell, Diffuse 223Lymphoma, Follicular 203Leukemia, Lymphocytic, Chronic, B-Cell 168Lymphoma, B-Cell 150Recurrence 130Burkitt Lymphoma 120Lymphoma, Mantle-Cell 115Leukemia, Myeloid, Acute 106Hodgkin Disease 102Leukemia 101Multiple Myeloma 95Lymphoma, B-Cell, Marginal Zone 88Neoplasms 81Myelodysplastic Syndromes 69Lymphoma, T-Cell, Peripheral 64Hematologic Neoplasms 61Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 58Lymphoma, T-Cell 51Lymphoma, T-Cell, Cutaneous 44Waldenstrom Macroglobulinemia 42Leukemia, Biphenotypic, Acute 35Mycosis Fungoides 32Lymphoproliferative Disorders 30Leukemia, B-Cell 30Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29Breast Neoplasms 28Myeloproliferative Disorders 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Advanced Solid Tumors × Lymphoid × Clear all
NCT06028373 2025-06-09

A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas

Antengene Corporation

Phase 1 Recruiting
80 enrolled
LymphoidOther solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡